Immunosuppression With 4SC-101, a Novel Inhibitor of Dihydroorotate Dehydrogenase, in a Rat Model of Renal Transplantation-Reference-Cited by-同舟云学术

Immunosuppression With 4SC-101, a Novel Inhibitor of Dihydroorotate Dehydrogenase, in a Rat Model of Renal Transplantation

Published:2012-06-15 Issue:11 Volume:93 Page:1101-1107
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Rusai Krisztina,Schmaderer Christoph,Baumann Marcus,Chmielewski Stefan,Prókai Ágnes,Kis Eva,Szabó Attila J.,Leban Johann,Doblhofer Robert,Ammendola Aldo,Lutz Jens,Heemann Uwe

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. Minimizing the risk of chronic allograft nephropathy.;Weir;Transplantation,2009

2. Leflunomide in clinical practice.;Pinto;Acta Reumatol Port,2006

3. Leflunomide controls rejection in hamster to rat cardiac xenografts.;Xiao;Transplantation,1994

4. . Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.;Kyles;Transplantation,2003

5. . A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.;Vincenti;Transplantation,2002

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022);Recent Patents on Anti-Cancer Drug Discovery;2024-08

2. Vidofludimus inhibits porcine reproductive and respiratory syndrome virus infection by targeting dihydroorotate dehydrogenase;Veterinary Research;2023-12-20

3. Advanced virtual screening enables the discovery of a host-targeting and broad-spectrum antiviral agent;Antiviral Research;2023-09

4. Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis;Acta Pharmaceutica Sinica B;2021-03

5. Dihydroorotate Dehydrogenase Inhibitors Promote Cell Cycle Arrest and Disrupt Mitochondria Bioenergetics in Ramos Cells;Current Pharmaceutical Biotechnology;2020-12-23